<DOC>
	<DOCNO>NCT01806558</DOCNO>
	<brief_summary>A combined molecular breast image / ultrasound system enable coregistration functional abnormality see Molecular Breast Imaging ( MBI ) correspond anatomical abnormality see ultrasound .</brief_summary>
	<brief_title>Pilot Study : Combined Molecular Breast Imaging/Ultrasound System Diagnostic Evaluation MBI-detected Lesions</brief_title>
	<detailed_description />
	<criteria>The pilot study comprise 12 woman age 40 old least one follow inclusion criterion : 1 . Have find mass lesion mammography breast MRI ( BIRADS 0 , 4 5 ) &gt; 0.5 cm &lt; 2 cm size additional workup focus ultrasound . 2 . Have find mass lesion ultrasound ( BIRADS 0 , 4 5 ) &gt; 0.5 cm &lt; 2 cm size . 3 . Have positive finding MBI &lt; 2 cm size require additional diagnostic workup focus ultrasound . 1 . Are unable understand sign consent form 2 . Are pregnant lactate 3 . Are physically unable sit upright still 40 minute 4 . Have undergone bilateral mastectomy 5 . Are scheduled undergo conventional ultrasound</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>molecular breast imaging</keyword>
	<keyword>breast</keyword>
	<keyword>breast lesion</keyword>
</DOC>